Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.

Cumulative Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Brain
low
GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds raise blood pressure (MK-677, YK-11). Monitor BP daily and consider cardiovascular support.
2x 2 compounds share the carcinogenic-risk safety flag (MK-677, YK-11). Monitor accordingly.
2x 2 hepatotoxic compounds (MK-677, YK-11). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (MK-677, YK-11). Monitor accordingly.
++
MK-677 + YK-11
Synergistic

MK-677 (Ibutamoren) is frequently combined with YK-11. MK-677 increases growth hormone and IGF-1 through ghrelin receptor agonism, which complements YK-11's AR-mediated and follistatin-mediated anabolic mechanisms through a completely independent pathway. MK-677 does not suppress testosterone and is not hepatotoxic, making it one of the safer adjuncts to a YK-11 cycle. The combination may enhance lean mass gains, recovery, and joint comfort (via GH-mediated collagen synthesis), potentially offsetting YK-11's reported joint dryness.

Researched 95% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.